SRT 2104

CAS No. : 1093403-33-8

SRT 2104,1093403-33-8
Product Details
For research use only. Not Intended for Therapeutic Use!
Cat No:I000394
Molecular Formula:C26H24N6O2S2
Molecular Weight:516.64
Price:Get quote
We would like to match the lowest price on market if possible.

Your information is safe with us.

Appearance:Solid powder
Purity: > 98%
Cat No:I000394
Cas No:1093403-33-8
Product-Name:SRT 2104

6-phenylimidazo[2,1-b]thiazole derivatives; SRT 2104.

[1]. Jiang WJ. Sirtuins: novel targets for metabolic disease in drug development. Biochem Biophys Res Commun. 2008 Aug 29;373(3):341-4. Abstract Calorie restriction extends lifespan and produces a metabolic profile desirable for treating diseases such as type 2 diabetes. SIRT1, an NAD(+)-dependent deacetylase, is a principal modulator of pathways downstream of calorie restriction that produces beneficial effects on glucose homeostasis and insulin sensitivity. Activation of SIRT1 leads to enhanced activity of multiple proteins, including peroxisome proliferator-activated receptor coactivator-1alpha (PGC-1alpha) and FOXO which helps to mediate some of the in vitro and in vivo effects of sirtuins. Resveratrol, a polyphenolic SIRT1 activator, mimics the effects of calorie restriction in lower organisms and in mice fed a high-fat diet ameliorates insulin resistance. In this review, we summarize recent research advances in unveiling the molecular mechanisms that underpin sirtuin as therapeutic candidates and discuss the possibility of using resveratrol as potential drug for treatment of diabetes.

Related Products
  • CAS No. :501-36-0
    Product Name:


    Cat No: A000646 View details
  • CAS No. :528-48-3
    Product Name:


    Cat No: R015004 View details
  • CAS No. :304896-21-7
    Product Name:


    Cat No: I011796 View details
  • CAS No. :5690-03-9
    Product Name:


    Cat No: R024357 View details